Precision BioSciences Inc (DTIL) — Cash Flow Quality Index

Latest as of December 2025: -0.56x

Precision BioSciences Inc (DTIL) has a Cash Flow Quality Index of -0.56x as of December 2025. Operating cash flow of $-11.25 Million is below net income of $20.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Precision BioSciences Inc cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.56x

Operating CF / Net Income

Operating Cash Flow

$-11.25 Million

USD

Net Income

$20.13 Million

USD

Data as of

Dec 2025

Most recent filing

Precision BioSciences Inc Cash Flow Quality Index (2024–2024)

Historical Cash Flow Quality Index for Precision BioSciences Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check DTIL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Precision BioSciences Inc (2024–2024)

Year-by-year earnings quality comparison for Precision BioSciences Inc. For live market cap and the full company financial profile, see Precision BioSciences Inc stock valuation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2024	-8.15x	$-58.45 Million	$7.17 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.